Melanocortin signaling in the CNS directly regulates circulating cholesterol

Cholesterol circulates in the blood in association with triglycerides and other lipids, and elevated blood low-density lipoprotein cholesterol carries a risk for metabolic and cardiovascular disorders, whereas high-density lipoprotein (HDL) cholesterol in the blood is thought to be beneficial. Circulating cholesterol is the balance among dietary cholesterol absorption, hepatic synthesis and secretion, and the metabolism of lipoproteins by various tissues. We found that the CNS is also an important regulator of cholesterol in rodents. Inhibiting the brain's melanocortin system by pharmacological, genetic or endocrine mechanisms increased circulating HDL cholesterol by reducing its uptake by the liver independent of food intake or body weight. Our data suggest that a neural circuit in the brain is directly involved in the control of cholesterol metabolism by the liver.

[1]  J. Auwerx,et al.  Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I , 2002, EMBO reports.

[2]  R. Hammer,et al.  Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. , 2005, The Journal of clinical investigation.

[3]  D. Cummings,et al.  Gastrointestinal regulation of food intake. , 2007, The Journal of clinical investigation.

[4]  Grace Guo,et al.  The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis* , 2003, The Journal of Biological Chemistry.

[5]  A. Rigotti,et al.  A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. W. Schwartz,et al.  Central nervous system control of food intake and body weight , 2006, Nature.

[7]  A. Tall,et al.  Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. , 2000, The Journal of clinical investigation.

[8]  A. Pocai,et al.  A brain-liver circuit regulates glucose homeostasis. , 2005, Cell metabolism.

[9]  Stephen B. H. Kent,et al.  In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. , 2009 .

[10]  B. Egan,et al.  Insulin resistance and cardiovascular disease. , 2001, American journal of hypertension.

[11]  B. AhrØn,et al.  Autonomic regulation of islet hormone secretion ± Implications for health and disease , 2000 .

[12]  T. Lundåsen,et al.  Leptin Induces the Hepatic High Density Lipoprotein Receptor Scavenger Receptor B Type I (SR-BI) but Not Cholesterol 7α-Hydroxylase (Cyp7a1) in Leptin-deficient (ob/ob) Mice* , 2003, Journal of Biological Chemistry.

[13]  K. Clément,et al.  Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. , 2000, The Journal of clinical investigation.

[14]  P. Tso,et al.  Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins , 2007, Nature Medicine.

[15]  S. Post,et al.  Phosphatidylinositol-3-Kinase Regulates Scavenger Receptor Class B Type I Subcellular Localization and Selective Lipid Uptake in Hepatocytes , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[16]  R. Cone.  Studies on the physiological functions of the melanocortin system. , 2006, Endocrine reviews.

[17]  M. Cowley,et al.  Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. , 2007, Cell metabolism.

[18]  A. Tall,et al.  Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Perrey,et al.  Severe Hypercholesterolemia, Hypertriglyceridemia, and Atherosclerosis in Mice Lacking Both Leptin and the Low Density Lipoprotein Receptor* , 2001, The Journal of Biological Chemistry.

[20]  M. Linton,et al.  Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M500181-JLR200 , 2005, Journal of Lipid Research.

[21]  J. Seufert,et al.  Nuclear Protein p8 Is Associated With Glucose-Induced Pancreatic β-Cell Growth , 2004 .

[22]  Michael Esterman,et al.  The Distribution and Mechanism of Action of Ghrelin in the CNS Demonstrates a Novel Hypothalamic Circuit Regulating Energy Homeostasis , 2003, Neuron.

[23]  J. Horton,et al.  SREBPs: transcriptional mediators of lipid homeostasis. , 2002, Cold Spring Harbor symposia on quantitative biology.

[24]  D. Cummings.  Ghrelin and the short- and long-term regulation of appetite and body weight , 2006, Physiology & Behavior.

[25]  M. Reilly,et al.  Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. , 2005, The Journal of clinical investigation.

[26]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[27]  E. Rubin,et al.  Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. , 2006, The Journal of clinical investigation.

[28]  R. Pittman,et al.  A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. , 1987, The Journal of biological chemistry.

[29]  F. Rohner-Jeanrenaud,et al.  The Leptin-Like Effects of 3-d Peripheral Administration of a Melanocortin Agonist Are More Marked in Genetically Obese Zucker (fa/fa) than in Lean Rats. , 2002, Endocrinology.

[30]  A. Tall,et al.  Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. , 1999, The Journal of biological chemistry.

[31]  S. Grundy.  Controversy in Clinical Endocrinology Metabolic Syndrome: a Multiplex Cardiovascular Risk Factor Mets as a Multiplex Cardiovascular Risk Factor , 2022 .

[32]  S. O’Rahilly,et al.  The Hormonal Control of Food Intake , 2007, Cell.

[33]  D. Rader.  Molecular regulation of HDL metabolism and function: implications for novel therapies. , 2006, The Journal of clinical investigation.

[34]  F. Ashcroft,et al.  Glucagon-Like Peptide 1 Stimulates Hypothalamic Proopiomelanocortin Neurons , 2007, The Journal of Neuroscience.

[35]  Bruce M. Spiegelman,et al.  Towards a molecular understanding of adaptive thermogenesis , 2000, Nature.

[36]  C. Mantzoros,et al.  Responsiveness to peripherally administered melanocortins in lean and obese mice. , 2004, Diabetes.

[37]  T. Horvath,et al.  Obesity and the neuroendocrine control of energy homeostasis: the role of spontaneous locomotor activity. , 2005, The Journal of nutrition.

[38]  M. Tschöp,et al.  Ghrelin induces adiposity in rodents , 2000, Nature.

[39]  S. O’Rahilly,et al.  The central melanocortin system directly controls peripheral lipid metabolism. , 2007, The Journal of clinical investigation.

[40]  M. Hulver,et al.  Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. , 2006, Endocrinology.

[41]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[42]  P. Ferré,et al.  Insulin and Angiotensin II Induce the Translocation of Scavenger Receptor Class B, Type I from Intracellular Sites to the Plasma Membrane of Adipocytes*[boxs] , 2005, Journal of Biological Chemistry.